About Manja Pharmaceuticals Private Limited
Data last updated:
Manja Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 October 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC156929. Its GSTIN is 27AAECM4561D1ZM (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Sangita Jitendra Bafna and Shanu Suresh Bafna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1103 11th Floor Plot – 1101 Aditya Enclave Khetwadi 12th Lane Girgaon, Mumbai, Maharashtra, India – 400004.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.6 Cr, a growth of 118% compared to the previous year. For the same year it recorded a net profit of ₹4.02 Lakh (net margin 2.5%) and EBITDA of ₹15.73 Lakh (EBITDA margin 9.8%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹7 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website manjapharma.tradeindia.com.
Company details
Contact details
Manja Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is manjapharma.tradeindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1103 11th Floor Plot – 1101 Aditya Enclave Khetwadi 12th Lane Girgaon, Mumbai, Maharashtra, India – 400004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Manja Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Manja Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Manja Pharmaceuticals Private Limited, buy the company report.
Financials of Manja Pharmaceuticals Private Limited
FY 2025 filings availableManja Pharmaceuticals Private Limited reported revenue of ₹1.6 Cr (up 118% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 118% growth in the latest year. EBITDA rose 336% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.73 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Manja Pharmaceuticals Private Limited, buy the company report.
Board of directors of Manja Pharmaceuticals Private Limited
Manja Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangita Jitendra Bafna | Director | 19 Aug 2022 | 4 Years 2 Months | Current |
| Shanu Suresh Bafna | Director | 19 Aug 2022 | 4 Years 2 Months | Current |
| Jitendra Lalchand Bafna | Director | 21 Oct 2005 | 21 Years 0 Months | Current |
| Manju Suresh Bafna | Director | 21 Oct 2005 | 21 Years 0 Months | Current |
Auditor
Manja Pharmaceuticals Private Limited is audited by VIJAY JOGANI & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIJAY JOGANI & CO | FY 2021 | 111409W |
Shareholding
The shareholding of Manja Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Manja Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 May 2006 | 10004715 | Dena Bank | ₹7 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Manja Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Manja Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Manja Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECM4561D1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Manja Pharmaceuticals Private Limited, buy the company report.
Recent activity
Manja Pharmaceuticals Private Limited has 4 board changes on record since 2005: 4 appointments. The latest: Sangita Jitendra Bafna was appointed as Director on 19 Aug 2022.
Frequently asked questions
Manja Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 October 2005 (21+ years old) and is registered under CIN U24230MH2005PTC156929.
Manja Pharmaceuticals has 4 current directors:
- Sangita Jitendra Bafna - Director
- Shanu Suresh Bafna - Director
- Jitendra Lalchand Bafna - Director
- Manju Suresh Bafna - Director
The latest financial statements of Manja Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Manja Pharmaceuticals is 27AAECM4561D1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Manja Pharmaceuticals is U24230MH2005PTC156929. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Manja Pharmaceuticals was incorporated on 13 October 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Sangita Jitendra Bafna was appointed as Director on 19 Aug 2022. Shanu Suresh Bafna was appointed as Director on 19 Aug 2022. Jitendra Lalchand Bafna was appointed as Director on 21 Oct 2005. Manja Pharmaceuticals has 4 board changes on record in total.
Manja Pharmaceuticals can be reached through the website manjapharma.tradeindia.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Manja Pharmaceuticals is at 1103 11th Floor Plot – 1101 Aditya Enclave Khetwadi 12th Lane Girgaon, Mumbai, Maharashtra, India – 400004.
Manja Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.